Grant support: NIH, National Cancer Institute grant CA084968,Onconome Inc., Patana Fund of the Brady Urological Institute. via Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer — Clinical Cancer Research 2008
Abgelegt unter: Z - Uncategorized Mit Tag(s) versehen: | 2008, Brady Urological Institute, CCSA-2, CCSA-3, CCSA-4, Clinical Cancer Research, Colon Cancer–Specific Antigen 2, Colorectal Cancer, Grant support, National Cancer Institute, NIH, Onconome, Patana Fund
